Reference
Faehling M, et al. Molecular profiling of EGFR-positive NSCLC with secondary T790M resistance mutation and tertiary transformation into small-cell lung cancer. Journal of Thoracic Oncology : S1259 abstr. P3.02b-109, Jan 2017 [abstract] -Germany
Rights and permissions
About this article
Cite this article
Erlotinib. Reactions Weekly 1658, 185 (2017). https://doi.org/10.1007/s40278-017-32382-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-32382-5